* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
HB00032 | Biotin-FA-FMK | 478.5834 | C23H31FN4O4S | Inquiry |
HB00033 | Z-LEVD-FMK | 652.7174 | C31H45FN4O10 | Inquiry |
HB00034 | Fitc-LEVD-FMK | 905.9924 | C45H52FN5O12S | Inquiry |
HB00035 | Biotin-LEVD-FMK | 728.859 | C32H52N6O11S | Inquiry |
HB00036 | Z-LLY-FMK | 557.6634 | C30H40FN3O6 | Inquiry |
HB00037 | Fitc-LLY-FMK | 810.3099 | C44H47FN4O8S | Inquiry |
HB00038 | Biotin-LLY-FMK | 649.8234 | C32H48FN5O6S | Inquiry |
HB00039 | Z-AEVD-FMK | 610.6364 | C28H39FN4O10 | Inquiry |
HB00040 | Fitc-AEVD-FMK | 863.9114 | C42H46FN5O12S | Inquiry |
HB00041 | Biotin-AEVD-FMK | 702.7964 | C30H47FN6O10S | Inquiry |
HB00042 | Z-LEED-FMK | 696.7264 | C32H45FN4O12 | Inquiry |
HB00043 | Fitc-LEED-FMK | 950.0014 | C46H52FN5O14S | Inquiry |
HB00044 | Biotin-LEED-FMK | 788.8864 | C34H53FN6O12S | Inquiry |
HB00045 | Z-YVAD-FMK | 630.6704 | C31H39FN4O9 | Inquiry |
HB00046 | Fitc-YVAD-FMK | 883.9454 | C45H46FN5O11S | Inquiry |
HB00047 | Biotin-YVAD-FMK | 722.8304 | C33H47FN6O9S | Inquiry |
HB00048 | Z-VDVAD-FMK | 695.7424 | C32H46FN5O11 | Inquiry |
HB00049 | Fitc-VDVAD-FMK | 949.0174 | C46H53FN6O13S | Inquiry |
HB00050 | Biotin-VDVAD-FMK | 787.9024 | C34H54FN7O11S | Inquiry |
HB00051 | Z-DQMD-FMK | 685.7214 | C29H40FN5O11S | Inquiry |
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
GR 82334 is a spirolactam analog with the structure of [[(S, S) Pro-Leu (spiro-γ-lactam)]9,10, Trp11] Physalaemi ...
Foreword We live in a photoshopped world, where we are constantly updated by images of digital perfection. It's easy to becom ...
The mammalian precursor gene proglucagon, which contains the glucagon sequence together with two structurally related glucago ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...
Iron chelating agent is a new type of iron-removing treatment based on the combination of directional and in viv ...